Cardinal Health Inc. (NYSE:CAH) is a key player in the healthcare sector, known for distributing pharmaceuticals and specialty products. The company also manufactures and distributes medical and laboratory products globally. It provides home-health and direct-to-patient services, operates nuclear pharmacies, and offers performance and data solutions. Cardinal Health competes with other major healthcare distributors.
On August 20, 2025, CEO Jason M. Hollar sold 12,944 shares of Cardinal Health at $149.40 each. This transaction was reported on Form 4, and Hollar now holds 222,957 shares. Such insider transactions can provide insights into the executive's perspective on the company's stock value and future prospects.
Cardinal Health's financial metrics offer a glimpse into its market standing. The company has a price-to-earnings (P/E) ratio of 23.42, indicating how much investors are willing to pay per dollar of earnings. Its price-to-sales ratio is 0.16, showing the market's valuation relative to revenue. These ratios help investors assess the company's valuation.
The company's enterprise value to sales ratio is 0.18, and its enterprise value to operating cash flow ratio is 17.18. These metrics provide insights into the company's valuation and cash flow efficiency. Cardinal Health's earnings yield is 4.27%, reflecting the return on investment for shareholders.
Cardinal Health's debt-to-equity ratio is -3.07, indicating its financial leverage. A negative ratio suggests more liabilities than equity. The current ratio of 0.94 shows its ability to cover short-term liabilities with short-term assets. These figures are crucial for understanding the company's financial health and risk profile.
